Literature DB >> 9354663

The human integrin beta3 gene is 63 kb and contains a 5'-UTR sequence regulating expression.

C C Wilhide1, Y Jin, Q Guo, L Li, S X Li, E Rubin, P F Bray.   

Abstract

The human blood platelet fibrinogen receptor, integrin alphaIIbbeta3 (glycoprotein IIb-IIIa) is an archetypal member of the integrin family of adhesive molecules and is the only integrin encoded by genes physically linked in the genome. Because studies on the normal and abnormal expression of any gene require a thorough understanding of its organization, the initial goals of the current study were to determine the size and complete the genomic organization for the beta3 gene. We now report the isolation of the entire beta3 gene in a single P1 plasmid and for the first time have linked the first and second exons on a contiguous fragment of DNA. Using pulsed-field gel analysis, we determined the full size of the beta3 gene to be 63 kb and show a large (16.7 kb) first intron; based on this information, we propose a uniform numbering system for the beta3 exons. We have completed the 5' genomic structure and generated a long-range restriction map. The promoter and the 5' end of the first intron were found to have approximately 50% sequence identity with a region of the avian beta3 gene known to possess functional transcriptional activity. Analysis of three different homologous regions led to the identification of a sequence in the 5'-UTR of the human gene, CCGCGGGAGG, which shares 90% identity with the avian gene and which bound nuclear proteins in DNaseI and electrophoretic mobility shift assay studies. Mutating this sequence caused a 2.6-fold reduction in reporter gene activity. In these studies we have (1) determined the full length and 5' organization of the beta3 gene, (2) identified a large region of homology between the 5' regions of the avian and human genes, and (3) identified a sequence in the 5'-UTR that augments gene expression. Knowing the genomic structure of beta3 has permitted the uncovering of new mechanisms of mutagenesis causing Glanzmann thrombasthenia (Jin et al, J Clin Invest 98:1745, 1996), and our findings will be valuable for such genetic analyses as well as for studies on the transcriptional regulation of beta3 and other integrin genes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9354663

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Beta3 integrin haplotype influences gene regulation and plasma von Willebrand factor activity.

Authors:  Katie E Payne; Paul F Bray; Peter J Grant; Angela M Carter
Journal:  Atherosclerosis       Date:  2007-11-28       Impact factor: 5.162

2.  Differential effects of HNF-1α mutations associated with familial young-onset diabetes on target gene regulation.

Authors:  Maria Galán; Carmen-Maria García-Herrero; Sharona Azriel; Manuel Gargallo; Maria Durán; Juan-Jose Gorgojo; Victor-Manuel Andía; Maria-Angeles Navas
Journal:  Mol Med       Date:  2010-12-15       Impact factor: 6.354

3.  Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.

Authors:  D Woods; H Cherwinski; E Venetsanakos; A Bhat; S Gysin; M Humbert; P F Bray; V L Saylor; M McMahon
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

4.  NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.

Authors:  Tania N Crotti; Merrilee Flannery; Nicole C Walsh; Joseph D Fleming; Steven R Goldring; Kevin P McHugh
Journal:  Gene       Date:  2006-03-02       Impact factor: 3.688

5.  Lrrc10 is a novel cardiac-specific target gene of Nkx2-5 and GATA4.

Authors:  Matthew J Brody; Eunjin Cho; Matthew R Mysliwiec; Tae-Gyun Kim; Clayton D Carlson; Kyu-Ho Lee; Youngsook Lee
Journal:  J Mol Cell Cardiol       Date:  2013-06-07       Impact factor: 5.000

Review 6.  Glanzmann thrombasthenia.

Authors:  Alan T Nurden
Journal:  Orphanet J Rare Dis       Date:  2006-04-06       Impact factor: 4.123

7.  Genome-wide functional analysis on the molecular mechanism of specifically biosynthesized fluorescence Eu complex.

Authors:  Jing Ye; Xiawei Dong; Xuerui Jiang; Hui Jiang; Chen-Zhong Li; Xuemei Wang
Journal:  Oncotarget       Date:  2017-07-01

8.  The effects of estrogen, its antagonist ICI 182, 780, and interferon-tau on the expression of estrogen receptors and integrin alphaV beta 3 on cycle day 16 in bovine endometrium.

Authors:  Sarah Kimmins; Gerald L Russell; Hai Choo Lim; Brian K Hall; Leslie A MacLaren
Journal:  Reprod Biol Endocrinol       Date:  2003-04-24       Impact factor: 5.211

9.  Molecular dynamics analysis of a novel β3 Pro189Ser mutation in a patient with glanzmann thrombasthenia differentially affecting αIIbβ3 and αvβ3 expression.

Authors:  Michel Laguerre; Essa Sabi; Martina Daly; Jacqueline Stockley; Paquita Nurden; Xavier Pillois; Alan T Nurden
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.